they were treated with 4-demethoxydaunorubicin ( idarubicin ) , a new anthracycline analog more active than daunorubicin ( dnr ) and doxorubicin ( dx ) in experimental tumor models which offers a higher therapeutic index than existing anthracyclines .
C0020789
idarubicin
C0011015
daunorubicin